Tony’s cancer treament on the MRIdian

Read how a pioneering radiotherapy treatment on the MRIdian, at GenesisCare Oxford helped Tony get treated for an otherwise inoperable cancer

“After being told his bowel cancer was inoperable Tony’s luck changed when his case was transferred to Dr James Good, Clinical Director of Stereotactic Radiotherapy at GenesisCare who suggested that Tony could benefit from treatment on the MRIdian Linac, a ground breaking new treatment offering hope to patients with difficult to treat tumours.  In June 2020 after just 3 sessions of treatment a PET/CT scan showed that the radiotherapy had been successful and that he is now in remission.  Tony recently shared his experience with the Malvern Gazette.  Read the full article here


Related articles

Honouring Clinical Excellence & Leadership: GenesisCare Launches Inaugural Global Physician Recognition Program

GenesisCare Appoints Seven Leading Oncologists to Chair its Global Research Committees

SABR Consortium Annual Professional Conference 2021

Annual research report 2020